Virbac Balance Sheet Health
Financial Health criteria checks 6/6
Virbac has a total shareholder equity of €909.9M and total debt of €87.2M, which brings its debt-to-equity ratio to 9.6%. Its total assets and total liabilities are €1.5B and €545.8M respectively. Virbac's EBIT is €186.1M making its interest coverage ratio 1177.8. It has cash and short-term investments of €178.4M.
Key information
9.6%
Debt to equity ratio
€87.16m
Debt
Interest coverage ratio | 1177.8x |
Cash | €178.40m |
Equity | €909.92m |
Total liabilities | €545.81m |
Total assets | €1.46b |
Recent financial health updates
Virbac (EPA:VIRP) Has A Pretty Healthy Balance Sheet
Oct 19Is Virbac (EPA:VIRP) Using Too Much Debt?
Apr 09Does Virbac (EPA:VIRP) Have A Healthy Balance Sheet?
Oct 14These 4 Measures Indicate That Virbac (EPA:VIRP) Is Using Debt Safely
Jun 26We Think Virbac (EPA:VIRP) Can Manage Its Debt With Ease
Mar 26Is Virbac (EPA:VIRP) Using Too Much Debt?
Oct 12Recent updates
Virbac SA (EPA:VIRP) Investors Are Less Pessimistic Than Expected
May 21Here's What Analysts Are Forecasting For Virbac SA (EPA:VIRP) After Its Yearly Results
Mar 22Is Virbac SA (EPA:VIRP) Trading At A 23% Discount?
Jan 18Virbac SA's (EPA:VIRP) Shares Climb 25% But Its Business Is Yet to Catch Up
Dec 27Virbac (EPA:VIRP) Has A Pretty Healthy Balance Sheet
Oct 19Is There An Opportunity With Virbac SA's (EPA:VIRP) 40% Undervaluation?
Sep 26Here's Why We Think Virbac (EPA:VIRP) Is Well Worth Watching
Sep 05A Look At The Fair Value Of Virbac SA (EPA:VIRP)
Jun 20Does Virbac (EPA:VIRP) Deserve A Spot On Your Watchlist?
May 31Is Virbac (EPA:VIRP) Using Too Much Debt?
Apr 09Are Investors Undervaluing Virbac SA (EPA:VIRP) By 34%?
Feb 28Virbac SA (EPA:VIRP) Shares Could Be 50% Below Their Intrinsic Value Estimate
Nov 25Does Virbac (EPA:VIRP) Have A Healthy Balance Sheet?
Oct 14An Intrinsic Calculation For Virbac SA (EPA:VIRP) Suggests It's 42% Undervalued
Aug 07These 4 Measures Indicate That Virbac (EPA:VIRP) Is Using Debt Safely
Jun 26Virbac SA (EPA:VIRP) Shares Could Be 38% Below Their Intrinsic Value Estimate
May 01We Think Virbac (EPA:VIRP) Can Manage Its Debt With Ease
Mar 26Virbac SA (EPA:VIRP) Shares Could Be 36% Below Their Intrinsic Value Estimate
Jan 26Here's Why I Think Virbac (EPA:VIRP) Is An Interesting Stock
Dec 28A Look At The Fair Value Of Virbac SA (EPA:VIRP)
Oct 27Is Virbac (EPA:VIRP) Using Too Much Debt?
Oct 12Here's Why I Think Virbac (EPA:VIRP) Might Deserve Your Attention Today
Sep 26Is Virbac SA (EPA:VIRP) Trading At A 22% Discount?
Jul 15Is Now The Time To Put Virbac (EPA:VIRP) On Your Watchlist?
Jun 27Is Virbac (EPA:VIRP) A Risky Investment?
May 27Robust Earnings May Not Tell The Whole Story For Virbac (EPA:VIRP)
Mar 24Are Investors Undervaluing Virbac SA (EPA:VIRP) By 32%?
Mar 12Here's Why We Think Virbac (EPA:VIRP) Is Well Worth Watching
Feb 22Is Virbac SA (EPA:VIRP) Popular Amongst Insiders?
Feb 03Virbac SA's (EPA:VIRP) Stock Is Going Strong: Is the Market Following Fundamentals?
Jan 05Does Virbac's (EPA:VIRP) Share Price Gain of 96% Match Its Business Performance?
Dec 18Estimating The Fair Value Of Virbac SA (EPA:VIRP)
Dec 01Here's Why I Think Virbac (EPA:VIRP) Might Deserve Your Attention Today
Nov 18Financial Position Analysis
Short Term Liabilities: VIRP's short term assets (€771.5M) exceed its short term liabilities (€399.0M).
Long Term Liabilities: VIRP's short term assets (€771.5M) exceed its long term liabilities (€146.8M).
Debt to Equity History and Analysis
Debt Level: VIRP has more cash than its total debt.
Reducing Debt: VIRP's debt to equity ratio has reduced from 97.9% to 9.6% over the past 5 years.
Debt Coverage: VIRP's debt is well covered by operating cash flow (136.1%).
Interest Coverage: VIRP's interest payments on its debt are well covered by EBIT (1177.8x coverage).